Oruka Therapeutics, Inc. (ORKA)
38.91
+0.09
(+0.23%)
USD |
NASDAQ |
Mar 20, 16:00
38.50
-0.41
(-1.05%)
After-Hours: 07:45
Oruka Therapeutics Shareholders Equity (Quarterly) : 471.93M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 193.93M |
| Liminatus Pharma, Inc. | -1.646M |
| Maze Therapeutics, Inc. | 379.44M |
| MapLight Therapeutics, Inc. | 233.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.62M |
| Total Liabilities (Quarterly) | 16.69M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 22.37 |
| Net Debt Paydown Yield | -0.01% |